Abstract:Abstract Dysregulation of lipid metabolism is observed during the development and progression of various types of cancer including prostate cancer (PCa). Systemic metabolic changes driven by genetic alterations in conjunction with obesity and a high-fat diet have been demonstrated to induce PCa progression. In this study, we aimed to investigate the impact of high- and low-fat diets on the progression and morbidity of prostate cancer, utilizing inducible genetically engineered mouse models (GEMMs) that mimic different grades of prostate cancer. The mice were initially placed on a standard diet until week 6, after which they were randomly assigned to either a low-fat or high-fat diet. At week 8, the Cre recombinase enzyme was activated to induce the desired phenotype in the GEMMs, effectively mimicking the initiation and progression of prostate cancer. The experimental design allowed us to gain insights into the interplay between dysregulated lipid metabolism, diet, and the pathogenesis of prostate cancer. Two groups of mice were taken for the study, with one group being fed a low-fat diet and the other group being fed a high-fat diet. The mice were maintained on their respective diets for a period of 1, 3, and 5 months. At each endpoint, tissue samples were collected. Samples were taken from the prostate, plasma, and liver tissues. These samples were then subjected to various analyses to investigate the changes occurring at the molecular and cellular level. Blood was collected to determine lipidomic content in response to high and low-fat diet and the relation of tumour progression. Finally, faecal samples were collected throughout the duration of the experiment to perform metagenomic studies. The consumption of a high-fat diet significantly increased the body weight of the mice which corresponded to increased liver weight. Furthermore, we identified that the consumption of a high-fat diet significantly correlated with an increase in prostate weight at 3 and 5 months after initiation. Preliminary metabolomic analysis of the plasma revealed a distinct clustering of samples based on the consumed diet. Metagenomic analyses conducted at 1 and 3 months indicated a visible shift in the composition and diversity of gut microbiota in mice fed either a high- or low-fat diet. In conclusion, our study will shed light on the influence of dietary factors on prostate cancer development, providing valuable information for the development of targeted therapeutic strategies to combat this disease. Citation Format: Saurav Subedi, Federico La Manna, Katja Ovchinnikova, Eugenio Zoni, Nicola Zamboni, Bahtiyar Yilmaz, George N. Thalmann, Marianna Kruithof-de Julio. Dysregulated lipid metabolism and high-fat diet influences prostate cancer (PCa) progression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4437.

Will Metformin Postpone High-Fat Diet Promotion of TRAMP Mouse Prostate Cancer Development and Progression?

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Figure S1 from Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Insulin-Like growth factor 1 related pathways and high-fat diet promotion of transgenic adenocarcinoma mouse prostate (TRAMP) cancer progression.

Figure S2 from Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Maternal High-Fat Diet Promotes the Development and Progression of Prostate Cancer in Transgenic Adenocarcinoma Mouse Prostate Offspring.

Combined Maternal and Post-Weaning High Fat Diet Inhibits Male Offspring's Prostate Cancer Tumorigenesis in Transgenic Adenocarcinoma of Mouse Prostate Model

High-fat diet-induced adipokine and cytokine alterations promote the progression of prostate cancer in vivo and in vitro .

Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways

High-fat diet promotes prostate cancer metastasis via RPS27

Early and Delayed Castrations Confer a Similar Survival Advantage in TRAMP Mice

Differential effects of omega-3 PUFAS on tumor progression at early and advanced stages in TRAMP mice

Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer

Vías relacionadas con IGF-1 (Insulin-like growth factor-1) y promoción de dieta alta en grasas en la progresión del cáncer de próstata en ratones TRAMP (Transgenic Adenocarcinoma of the Mouse Prostate)

Suppressive Effects of Metformin on Colorectal Adenoma Incidence and Malignant Progression

Abstract 4437: Dysregulated lipid metabolism and high-fat diet influences prostate cancer (PCa) progression

A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice

Effect Of Metformin On Cancer Risk And Treatment Outcome Of Prostate Cancer: A Meta-Analysis Of Epidemiological Observational Studies

An Open-Label Pilot Study of Metformin As a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment

Palliative effects of metformin on testicular damage induced by triptolide in male rats

Metformin Inhibits Tumor Metastasis Through Suppressing Hsp90 Alpha Secretion In An Ampk Alpha 1-Pkc Gamma Dependent Manner